Skip to main content

Startups & scaleups

Startups and scaleups are driving the growth of the BioRegion of Catalonia. Overall, in 2025 they raised €517 million in investment. Since 2014, the pace of startup creation has remained steady, with more than one new company founded each week. Twenty-six percent of healthcare startups in Catalonia are spinoffs from research institutions, and 32% of emerging companies are led by women.

 splicebio

Splice Bio

Splice Bio uses protein splicing to push the limits of adeno-associated virus (AAV) vector applications and develop gene therapies for large genes.

Sector: Biotec
Subsector: Medicines and diagnosis
Investment secured

Historic record in investment in healthcare startups and scaleups, reaching €517 million

After any complication in the global geo-political and economic context in terms of investment indicators for the BioRegion in 2023, by 2024 the BioRegion has recovered its embryonic status. 2025 marks an unprecedented milestone: investment in startups and scaleups reached €517 million, a 43% increase compared to 2024 and 7% above the previous peak recorded in 2022.

Startups working on health AI

116 startups and scaleups are working on health AI in Catalonia in 2025

The AI ecosystem applied to healthcare in Catalonia continues to expand, reaching 172 companies in 2025, an 11% increase compared to 2024. Of these, 116 are startups (67%), and an emerging subsegment of 12 generative AI companies has been identified.

Featured startups

 impress

Impress

Impress specializes in invisible orthodontics and uses the most advanced technology for diagnosing and improving oral health. They closed a €122 million round in 2022.

Sector: Tecmed
Subsector: Medical devices
Minoryx Therapeutics

Minoryx Therapeutics

Minoryx develops therapies for orphan diseases of the central nervous system. In May 2022, the company closed a €51 million Series C round and in November licensed its drug leriglitazone for X-ALD.

Sector: Biotec
Subsector: Medicines and diagnosis
 splicebio

Splice Bio

Splice Bio uses protein splicing to push the limits of adeno-associated virus (AAV) vector applications and develop gene therapies for large genes.

Sector: Biotec
Subsector: Medicines and diagnosis
neuroelectrics

Neuroelectris

A company that has developed a medical device for non-invasive electrical brain stimulation for personalised neuromodulation. This device measures and modifies brain function to restore health, minimise disability and improve patients' lives.

Sector: Tecmed
Subsector: Medical devices
HumanITCare

HumanITCare

HumanITCare has developed a telemedicine platform that allows for remote medical monitoring, provides at home care and compiles data in real time for research.

Sector: Digital health
Subsector: Digital therapies (DTx)
Mowoot

UsMIMA (MowoOt)

UsMIMA has developed a medical device (MowoOt), inspired by the abdominal massages of the Institut Guttman therapists, for chronic constipation. It is the first startup created from the d·HEALTH Barcelona program.

Sector: Tecmed
Subsector: Medical devices
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.